Cochlear gene therapy: current perspectives

scientific article

Cochlear gene therapy: current perspectives is …
instance of (P31):
scholarly articleQ13442814
review articleQ7318358

External links are
P356DOI10.1016/S0165-5876(99)00127-5
P698PubMed publication ID10577770

P2093author name stringLalwani AK
Wareing MJ
P2860cites workIn vivo gene delivery and stable transduction of nondividing cells by a lentiviral vectorQ29547503
Science, medicine, and the future. Gene therapyQ40876824
Defective HSV-1 vector expressing BDNF in auditory ganglia elicits neurite outgrowth: model for treatment of neuron loss following cochlear degenerationQ41237702
Cationic liposome mediated transgene expression in the guinea pig cochleaQ41614363
Transgene expression in the guinea pig cochlea mediated by a lentivirus-derived gene transfer vectorQ41685193
Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brainQ42280576
Long-term in vivo cochlear transgene expression mediated by recombinant adeno-associated virusQ44136141
Restoration of brain stem auditory-evoked potentials by gene transfer in shiverer miceQ45866198
The TMC Worldwide Gene Therapy Enrollment Report, end 1996.Q45881392
Gene therapy -- promises, problems and prospectsQ45883584
NT-3 and/or BDNF therapy prevents loss of auditory neurons following loss of hair cellsQ49052948
Adenoviral-mediated gene transfer into guinea pig cochlear cells in vivo.Q50515400
Regeneration of the tectorial membrane in the chick cochlea following severe acoustic trauma.Q50575882
Mammalian vestibular hair cell regenerationQ72485240
P921main subjectgene therapyQ213901
P304page(s)S27-30
P577publication date1999-10-01
P1433published inInternational Journal of Pediatric OtorhinolaryngologyQ2602426
P1476titleCochlear gene therapy: current perspectives
P478volume49 Suppl 1

Reverse relations

Q35161988Direct visualization of the murine dorsal cochlear nucleus for optogenetic stimulation of the auditory pathway.cites workP2860